ArticleJournal of autism and developmental disorders2026
Autism Spectrum Disorder (ASD) Through the Lens of Hidden Markov Models (HMMs) Applied to Resting-State fMRI (rs-fMRI): A Systematic Review and Meta-analysis.
Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAutism spectrum disorder (ASD) is a neurodevelopmental condition characterized by atypical interactions between brain networks. These interactions and the resulting dynamic shifts are effectively captured by Hidden Markov Models (HMMs) in comparison to static functional connectivity (FC)-based approaches. This review aims to meta-analyze the application of HMM to resting-state fMRI (rs-fMRI) in individuals with ASD.
methodsA systematic search of PubMed, Scopus, and Web of Science was conducted in May 2025. Screening followed PRISMA 2020 guidelines, with independent review and consensus resolution. Eligible studies were peer-reviewed, English-language publications that have applied HMMs to rs-fMRI in ASD, with either classification performance or state-metric outcomes reported.
resultsSeven studies met eligibility criteria. HMM-derived metrics demonstrated diagnostic utility, with a pooled log odds ratio (log OR) of 2.86 (95% CI: 1.74-3.98; z = 5.01, p < 0.001; I² = 92%) and a pooled AUC of 0.85 (95% CI: 0.72-0.98; I² = 96.9%). Substantial heterogeneity exists across both accuracy outcomes. Relative to typically developing controls, individuals with ASD showed markedly reduced mean lifetime (MLT) in default mode network (DMN)-associated states (pooled Hedges' g = -4.19; 95% CI: -5.52 to -2.85; I² = 98%) and prolonged MLT in sensory/attention hyperactivation states (g = 3.80; 95% CI: 3.43-4.16; I² = 65%), the latter rated as high certainty evidence. Fractional occupancy (FO) in DMN states was also substantially reduced (g = -6.22; 95% CI: -9.87 to -2.58; I² = 99.6%), though this outcome was rated low certainty. Narrative synthesis across consistently identified reduced FO and MLT in DMN-hypersynchrony states alongside increased occupancy in sensory-motor and attention states, replicated across two studies despite variation in atlas choice, number of HMM states, and participant samples. HMM-derived metrics were significantly negatively correlated with ADOS scores (pooled r = -0.20; 95% CI: -0.27 to -0.13; I² = 0%; p < 0.001), rated as high certainty evidence. Transition probability analyses, reported narratively due to incompatible state taxonomies, indicated reduced transitions from sensory-related to DMN-related states and increased self-transitions in sensory-motor states in ASD. Overall risk of bias was low to moderate, with incomplete confounder adjustment being the most common limitation.
conclusionsASD involves rigid, imbalanced temporal dynamics, with reduced engagement of integrative networks and dominance of sensory states. Leveraging its high diagnostic accuracy, HMMs capture these alterations and hold promise for mechanistic insight and personalized diagnostics, though heterogeneity remains a challenge. REVIEW REGISTRATION: PROSPERO CRD420251057196.
Indexed as
Identifiers
42627436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.